Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Psilocybin by Ceruvia Lifesciences for Cluster Headache Syndrome (Cluster Headache): Likelihood of Approval
Psilocybin is under clinical development by Ceruvia Lifesciences and currently in Phase I for Cluster Headache Syndrome (Cluster Headache). According...
Psilocybin by Ceruvia Lifesciences for Smoking Cessation: Likelihood of Approval
Psilocybin is under clinical development by Ceruvia Lifesciences and currently in Phase II for Smoking Cessation. According to GlobalData, Phase...
NYPRG-101 by Ceruvia Lifesciences for Alcohol Dependence: Likelihood of Approval
NYPRG-101 is under clinical development by Ceruvia Lifesciences and currently in Phase I for Alcohol Dependence. According to GlobalData, Phase...
NYPRG-101 by Ceruvia Lifesciences for Opium (Opioid) Addiction: Likelihood of Approval
NYPRG-101 is under clinical development by Ceruvia Lifesciences and currently in Phase I for Opium (Opioid) Addiction. According to GlobalData,...
Psilocybin by Ceruvia Lifesciences for Smoking Cessation: Likelihood of Approval
Psilocybin is under clinical development by Ceruvia Lifesciences and currently in Phase II for Smoking Cessation. According to GlobalData, Phase...